arrow_back Civic Audit
Share share

Affordable Insulin for Youth: Lower Costs, No Deductibles

New regulations aim to reduce insulin costs for individuals aged 26 and younger with private health insurance. Starting in 2026, insurers will be prohibited from applying deductibles or imposing high co-payments for insulin, making the medication more accessible and easing financial burdens for families.
Key points
Individuals aged 26 and younger with private health insurance will pay a maximum of $35 or 25% of the negotiated price for a 30-day supply of insulin.
Insurers will not be allowed to apply deductibles for selected insulin products for this age group.
Cost-sharing payments for insulin will count towards annual out-of-pocket maximums.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_2636
Sponsor: Rep. Landsman, Greg [D-OH-1]
Process start date: 2025-04-03
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Making Insulin Affordable for All Children Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2636.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-03.

What are the main provisions?

Key points include:

  • Individuals aged 26 and younger with private health insurance will pay a maximum of $35 or 25% of the negotiated price for a 30-day supply of insulin.
  • Insurers will not be allowed to apply deductibles for selected insulin products for this age group.
  • Cost-sharing payments for insulin will count towards annual out-of-pocket maximums.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Landsman, Greg [D-OH-1].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Family